Our CBD oil products have been approved for medicinal cannabis use in Brazil under the ANVISA programme; ANVISA is Brazil’s regulator, comparable to the US FDA. This is a big statement by the Brazilian government, which shows their efforts to regulate the booming medical cannabis market and make sure that only the safest and highest quality products get sold to their citizens.
Thanks to our really high quality standards and the very low THC concentration of under 0.2% or even under 0.0% in our products, Formula Swiss is currently one of just three companies that can legally deliver CBD and medicinal cannabis to doctors and patients in Brazil. We have been delivering directly to patients in Brazil for over 6 months now.
Considering the market opportunity of 209 million people and more than 550,000 doctors, we are very excited and humbled by this opportunity. We hope to gain widespread acceptance and trust from the Brazilian people in the near future.
You can read the full article about this at Forbes.com.
